wr 99210 has been researched along with alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol in 1 studies
Studies (wr 99210) | Trials (wr 99210) | Recent Studies (post-2010) (wr 99210) | Studies (alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol) | Trials (alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol) | Recent Studies (post-2010) (alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol) |
---|---|---|---|---|---|
59 | 0 | 12 | 6 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghaffar, A; Krech, L; Wood, D | 1 |
1 other study(ies) available for wr 99210 and alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol
Article | Year |
---|---|
Immunomodulation by novel antimalarial chemotherapeutic agents.
Topics: Animals; Antibody Formation; Antimalarials; Erythrocytes; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Immunity; Male; Mice; Mice, Inbred BALB C; Phenanthrenes; Triazines | 1984 |